14-day Premium Trial Subscription Try For FreeTry Free
OTCBB:TLOG
Delisted

TetraLogic Pharmaceuticals Corporation Stock Price (Quote)

$0.0401
-0.0062 (-13.30%)
At Close: Oct 31, 2017

Range Low Price High Price Comment
30 days $0.0300 $0.0500 Tuesday, 31st Oct 2017 TLOG stock ended at $0.0401. This is 13.30% less than the trading day before Monday, 30th Oct 2017. During the day the stock fluctuated 12.50% from a day low at $0.0400 to a day high of $0.0450.
90 days $0.0100 $0.0500
52 weeks $0.0100 $0.169

Historical TetraLogic Pharmaceuticals Corporation prices

Date Open High Low Close Volume
Oct 31, 2017 $0.0450 $0.0450 $0.0400 $0.0401 6 710
Oct 30, 2017 $0.0420 $0.0460 $0.0420 $0.0463 5 615
Oct 27, 2017 $0.0500 $0.0500 $0.0460 $0.0463 12 044
Oct 26, 2017 $0.0460 $0.0460 $0.0400 $0.0450 24 775
Oct 25, 2017 $0.0480 $0.0480 $0.0400 $0.0403 44 127
Oct 24, 2017 $0.0400 $0.0430 $0.0400 $0.0430 8 260
Oct 23, 2017 $0.0400 $0.0400 $0.0400 $0.0400 48 500
Oct 20, 2017 $0.0450 $0.0500 $0.0400 $0.0416 235 380
Oct 19, 2017 $0.0440 $0.0450 $0.0440 $0.0450 7 678
Oct 18, 2017 $0.0350 $0.0500 $0.0330 $0.0330 106 152
Oct 17, 2017 $0.0410 $0.0410 $0.0320 $0.0322 4 238
Oct 16, 2017 $0.0300 $0.0500 $0.0300 $0.0500 9 395
Oct 13, 2017 $0.0450 $0.0450 $0.0320 $0.0321 17 705
Oct 12, 2017 $0.0320 $0.0350 $0.0320 $0.0349 20 928
Oct 11, 2017 $0.0320 $0.0320 $0.0320 $0.0325 1 000
Oct 10, 2017 $0.0410 $0.0410 $0.0320 $0.0320 3 464
Oct 09, 2017 $0.0330 $0.0330 $0.0330 $0.0333 36
Oct 06, 2017 $0.0360 $0.0360 $0.0330 $0.0333 7 500
Oct 05, 2017 $0.0450 $0.0500 $0.0360 $0.0359 65 511
Oct 04, 2017 $0.0420 $0.0460 $0.0420 $0.0449 22 537
Oct 03, 2017 $0.0440 $0.0440 $0.0410 $0.0411 23 215
Oct 02, 2017 $0.0400 $0.0450 $0.0400 $0.0450 184 839
Sep 29, 2017 $0.0350 $0.0400 $0.0350 $0.0350 50 843
Sep 28, 2017 $0.0350 $0.0350 $0.0250 $0.0350 20 700
Sep 27, 2017 $0.0280 $0.0370 $0.0200 $0.0373 130 377
Click to get the best stock tips daily for free!

About TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is... TLOG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT